We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00193089
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : December 10, 2015
Sponsor:
Collaborators:
Aventis Pharmaceuticals
GlaxoSmithKline
Information provided by (Responsible Party):
SCRI Development Innovations, LLC